deferiprone has been researched along with Cochlear Hearing Loss in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanphaichitr, A | 1 |
| Kusuwan, T | 1 |
| Limviriyakul, S | 1 |
| Atipas, S | 1 |
| Pooliam, J | 1 |
| Sangpraypan, T | 1 |
| Tanphaichitr, VS | 1 |
| Viprakasit, V | 1 |
| Osma, U | 1 |
| Kurtoglu, E | 1 |
| Eyigor, H | 1 |
| Yilmaz, MD | 1 |
| Aygener, N | 1 |
2 other studies available for deferiprone and Cochlear Hearing Loss
| Article | Year |
|---|---|
Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
Topics: Adolescent; Adult; Benzoates; Chelation Therapy; Child; Child, Preschool; Deferasirox; Deferiprone; | 2014 |
Sensorineural hearing loss in β-thalassemia patients treated with iron chelation.
Topics: Adolescent; Adult; Audiometry, Pure-Tone; Benzoates; beta-Thalassemia; Child; Child, Preschool; Cros | 2015 |